Health and Fitness Health and Fitness
Thu, December 2, 2010
[ Thu, Dec 02nd 2010 ] - Market Wire
Apricus Biosciences bestimmt Produzenten fr Vitar .. edikament zur Behandlung von Erektionsstrungen in
[ Thu, Dec 02nd 2010 ] - Market Wire
Apricus Biosciences nomina il produttore canadese .. di nuova approvazione per il trattamento della di
[ Thu, Dec 02nd 2010 ] - Market Wire
Apricus Biosciences stelt producent aan voor Vita .. de geneesmiddel voor erectiestoornissen in Canada
Wed, December 1, 2010
[ Wed, Dec 01st 2010 ] - Market Wire
Amsterdam Molecular Therapeutics Amends Amgen GDNF Gene License Agreement
[ Wed, Dec 01st 2010 ] - Market Wire
Accuray Incorporated, Varian Medical, TomoTherapy, GlaxoSmithKline Plc and Theravance
[ Wed, Dec 01st 2010 ] - Market Wire
MannKind to Present at the Canaccord Genuity 5th .. ual Cardiovascular, Diabetes & Obesity Conference
[ Wed, Dec 01st 2010 ] - Market Wire
Exelixis Announces Webcast of Annual R&D Day on December 2
[ Wed, Dec 01st 2010 ] - Market Wire
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
[ Wed, Dec 01st 2010 ] - Market Wire
Apricus Biosciences Appoints Manufacturer for Vit .. oved Drug to Treat Erectile Dysfunction in Canada
[ Wed, Dec 01st 2010 ] - Market Wire
CIGNA Announces Tender Offer for any and all of its 8.50% Senior Notes due 2019
[ Wed, Dec 01st 2010 ] - Market Wire
Bristol-Myers Squibb and Alvin Ailey American Dan .. -Its-Kind Collaboration to Express the Stories of
[ Wed, Dec 01st 2010 ] - Market Wire
Oncolytics Biotech® Inc. Announces Start of .. lment in Randomized Phase II Ovarian Cancer Study
[ Wed, Dec 01st 2010 ] - Market Wire
Medisafe 1 Technologies Locking Syringe Adds ERP Compatibility Feature
[ Wed, Dec 01st 2010 ] - Market Wire
Aetna Names Michael Mathias Chief Information Officer
[ Wed, Dec 01st 2010 ] - Market Wire
CytRx Initiating Phase 2b Clinical Trial with Tamibarotene in Advanced Lung Cancer
[ Wed, Dec 01st 2010 ] - Market Wire
Genzyme Completes Sale of Genetic Testing Business to LabCorp
[ Wed, Dec 01st 2010 ] - Market Wire
LabCorp Successfully Completes Acquisition of Genzyme Genetics
[ Wed, Dec 01st 2010 ] - Market Wire
Synovis Life Technologies Reports 21 Percent Year .. ear Revenue Growth for Fiscal 2010 Fourth Quarter
[ Wed, Dec 01st 2010 ] - Market Wire
Allos Therapeutics Announces FOLOTYN® Data to Be .. t the 2010 Chicago Multidisciplinary Symposium in
[ Wed, Dec 01st 2010 ] - Market Wire
MEDNAX Announces the Acquisition of Washington State Pediatric Critical Care Practice
[ Wed, Dec 01st 2010 ] - Market Wire
BioScrip Appoints David W. Froesel, Jr. as Execut .. President, Chief Financial Officer and Treasurer
[ Wed, Dec 01st 2010 ] - Market Wire
OSI Pharmaceuticals, Inc. Exercises Option under .. nd Translational Research Collaboration with AVEO
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
Teva Announces $1 Billion Share Repurchase Program
[ Tue, Nov 30th 2010 ] - Market Wire
NeuroMetrix to Present at Canaccord Genuity 5th Cardiovascular, Diabetes & Obesity Conference
[ Tue, Nov 30th 2010 ] - Market Wire
Gilead Sciences to Present at the NASDAQ OMX 25th Investor Program
[ Tue, Nov 30th 2010 ] - Market Wire
HealthSpring, Inc. Completes Acquisition of Bravo Health, Inc.
[ Tue, Nov 30th 2010 ] - Market Wire
InSite Vision Names Timothy Ruane Chief Executive Officer
[ Tue, Nov 30th 2010 ] - Market Wire
Micromet to Present at the 2010 Piper Jaffray Healthcare Conference
[ Tue, Nov 30th 2010 ] - Market Wire
Spectranetics to Present at the 5th Annual Canacc .. ular, Diabetes & Obesity Conference on December 7
[ Tue, Nov 30th 2010 ] - Market Wire
Ruim 260 presentaties en posters over producten v .. tijdens 52ste jaarvergadering van American Societ

Ruim 260 presentaties en posters over producten van Celgene worden aangestipt tijdens 52ste jaarvergadering van American Societ


Published on 2010-11-30 08:36:11 - Market Wire
  Print publication without navigation


BOUDRY, Switzerland--([ BUSINESS WIRE ])--Celgene International Srl (NASDAQ: CELG) maakt vandaag bekend dat klinische onderzoekers van vooraanstaande kankeronderzoekcentra gegevens zullen presenteren van recent afgeronde en nog lopende klinische proeven. Dit gaan zij doen door middel van ruim 260 posters en presentaties, waaronder ruim 65 mondelinge presentaties over de producten van Celgene tegen bloedkanker. Een en ander vindt plaats van 4-7 december tijdens de 52ste jaarvergadering van de American Society of Hematology in Orlando, Florida. Surf naar www.hematology.org voor meer informatie.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Contributing Sources